In order to successfully invest in and realise the potential of advanced therapies, several technical factors must be well understood and influence decision-making to mitigate risk
You may have seen the Advanced Therapies Investment report but may not have had time to read all 115 pages?
The report itself examines the critical stages of developing advanced therapies, which include design and optimisation of bioprocessing; testing and validation; clinical development; supply chain and market access strategy. It is broken down into six chapters covering these main risk factors, providing the perfect guide for this burgeoning industry and helping to ensure you see a return on your investments.
No time to read the whole thing? To help you digest this crucial guide to investing in ATMPs, we have an infographic that gives you a quick overview the main findings of each of the six chapters.